Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
World J Surg Oncol ; 21(1): 274, 2023 Sep 01.
Article in English | MEDLINE | ID: mdl-37658451

ABSTRACT

OBJECTIVE: To report a rare gastroblastoma; discuss its clinical features, histopathological morphology, diagnosis, differential diagnosis, treatment, and prognosis; and so as to improve the understanding on this disease and provide reference for its diagnosis, treatment, and prognosis. METHODS: The diagnosis and treatment, imaging examination, pathological, and genetic data of a 19-year-old young female patient with gastroblastoma were analyzed retrospectively, and the relevant literature was reviewed and summarized. RESULTS: The patient was found to have a "gastrointestinal stromal tumor" for 3 days by physical examination in another hospital. Abdominal CT and MRI considered "solid pseudopapilloma of pancreas" and clinically planned to perform "radical pancreatoduodenectomy." During the operation, the tumor was observed to bulge from the posterior wall of the gastric antrum, and the root was located in the gastric antrum, so it was changed to "partial gastrectomy + Ronx-y gastrojejunal anastomosis." The postoperative pathology showed that the tumor was bi-differentiated between gastric epithelium and mesenchymal. Combined with the results of IHC and the opinions of several consultation units, the diagnosis of gastric blastoma (low-grade malignancy) was supported. However, the fracture rearrangement of GLI1 and EWSR1 genes was not detected by FISH. After 19 months of follow-up, no signs of tumor recurrence and metastasis were found. CONCLUSION: Combined with existing literature reports, gastroblastoma occurs in young people, equally in men and women, and tends to occur in the gastric antrum. The biological behavior of the tumor tends to be inert, and the prognosis of most cases is good. Postoperative pathology and IHC are reliable methods for the diagnosis of gastric blastoma, and surgical resection of the lesion is the preferred treatment.


Subject(s)
Neoplasm Recurrence, Local , Stomach Neoplasms , Female , Humans , Male , Zinc Finger Protein GLI1/genetics , Retrospective Studies , Stomach Neoplasms/genetics , Stomach Neoplasms/surgery , RNA-Binding Protein EWS
2.
Anim Biotechnol ; 31(1): 59-66, 2020 Feb.
Article in English | MEDLINE | ID: mdl-30431388

ABSTRACT

Signal transducer and activator 5 (STAT5) plays important roles in regulating mammary glandular cell proliferation and milk-protein gene expression. However, the functions of STAT5a and STAT5b genes in lactation of buffalo remain uninvestigated. In this study, full-length STAT5a (2502 bp) and STAT5b (2515 bp) coding sequences were isolated for the first time. The highest STAT5a gene expression was found in buffalo mammary glands and the highest STAT5b gene expression was found in buffalo brains and mammary glands. H&E staining indicated that STAT5a and STAT5b are mainly expressed in epithelial cells of buffalo mammary glands. Next, we investigated the functions of STAT5 by knocking down and overexpressing STAT5 in buffalo mammary epithelial cells (BuMECs). According to our results, STAT5 knockdown resulted in inhibited G1/S transition of BuMECs and significantly lower expression of milk-protein genes, whereas overexpression of STAT5 resulted in significantly higher expression of milk-protein genes. In summary, our results demonstrate that STAT5 can regulate the cell cycle transition of BuMECs and affect the expression of milk-protein genes. Our research lays a foundation for further study of the role of STAT5 in mammary gland development and lactation.


Subject(s)
Buffaloes/genetics , Milk Proteins/genetics , STAT5 Transcription Factor/metabolism , Signal Transduction , Animals , Buffaloes/physiology , Cell Cycle/genetics , Cell Proliferation/genetics , Epithelial Cells/physiology , Female , Lactation , Mammary Glands, Animal/physiology , STAT5 Transcription Factor/genetics
3.
Cell Mol Biol Lett ; 19(4): 623-37, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25355240

ABSTRACT

CD14 plays a crucial role in the inflammatory response to lipopolysaccharide (LPS), which interacts with TLR4 and MD-2 to enable cell activation, resulting in inflammation. Upstream inhibition of the inflammation pathway mediated by bacterial LPS, toll-like receptor 4 (TLR4) and cluster of differentiation antigen 14 (CD14) was proven to be an effective therapeutic approach for attenuating harmful immune activation. To explore the effect of CD14 downregulation on the expression of TLR4 signaling pathway-related genes after LPS stimulation in buffalo (Bubalus bubalis) monocyte/macrophages, effective CD14 shRNA sequences were screened using qRT-PCR and FACS analysis with buffalo CD14 shRNA lentiviral recombinant plasmids (pSicoRGFP-shRNA) and buffalo CD14 fusion expression plasmids (pDsRed-N1-buffalo CD14) co-transfected into HEK293T cells via liposomes. Of the tested shRNAs, shRNA-1041 revealed the highest knockdown efficiency (p < 0.01). When buffalo peripheral blood monocyte/macrophages were infected with shRNA-1041 lentivirus and stimulated with LPS, the expression of endogenous CD14 was significantly decreased by CD14 shRNA (p < 0.01), and the mRNA expression levels of TLR4, IL-6 and TNF-α were also significantly downregulated compared to the control groups (p < 0.01). These results demonstrated that the knockdown of endogenous CD14 had clear regulatory effects on the signal transduction of TLR4 after stimulation with LPS. These results may provide a better understanding of the molecular mechanisms of CD14 regulation in the development of several buffalo diseases.


Subject(s)
Lipopolysaccharide Receptors/genetics , Macrophages/metabolism , RNA, Small Interfering/genetics , Toll-Like Receptor 4/genetics , Animals , Buffaloes , Cells, Cultured , Gene Knockdown Techniques , HEK293 Cells , Humans , Lipopolysaccharide Receptors/metabolism , Lipopolysaccharides/pharmacology , Macrophages/immunology , Signal Transduction , Toll-Like Receptor 4/metabolism
4.
Cell Reprogram ; 23(3): 158-167, 2021 06.
Article in English | MEDLINE | ID: mdl-33956517

ABSTRACT

Past researches have shown that pluripotency maintenance of naive and primed-state pluripotent stem cells (PSCs) depends on different signaling pathways, and naive-state PSCs possess the ability to produce chimeras when they are introduced into a blastocyst. Considering porcine is an attractive model for preclinical studies, many researches about pig induced pluripotent stem cells (piPSCs) have been reported. Some cytokines and small molecule compounds could transform primed piPSCs into naive state. However, there are no suitable culture conditions for generation of naive-state piPSCs with high efficiency; other small molecule compounds need further exploration. In this study, we investigated whether p38 MAPK and JNK signal pathway inhibitor SB203580 and SP600125 could be of benefit for acquiring naive-state piPSCs. By comparing reprogramming efficiencies under conditions of different donor cells and culture environment, we found that porcine bone marrow mesenchymal stem cells (PBMSCs) have higher efficiency on piPSC induction, and the culture condition of CHIR99021+PD0325901(2i)+Lif+bFGF is more suitable for subculturing of piPSCs. Our results also indicate that SB203580 and SP600125 could promote reprogramming of PBMSCs into naive-like state piPSCs. These results provide guidance for choosing donor cells, culture conditions, and research of different state iPSCs during the process of reprogramming pig somatic cells.


Subject(s)
Anthracenes/pharmacology , Cell Differentiation , Cellular Reprogramming , Imidazoles/pharmacology , Induced Pluripotent Stem Cells/cytology , Mesenchymal Stem Cells/cytology , Pyridines/pharmacology , Animals , Enzyme Inhibitors/pharmacology , Induced Pluripotent Stem Cells/drug effects , Mesenchymal Stem Cells/drug effects , Swine , Swine, Miniature
5.
Cell Reprogram ; 21(5): 229-237, 2019 10.
Article in English | MEDLINE | ID: mdl-31479283

ABSTRACT

Pig-induced pluripotent stem cells (piPSCs) have great potential application in regenerative medicine. The miR-302s cluster alone has been shown to reprogram mouse and human somatic cells into induced pluripotent stem cells (iPSCs) without exogenous transcription factors. However, miR-302s alone have not been reported to reprogram cells in large livestock. In this study, we induced pig somatic cells into partially reprogrammed piPSCs using overexpression of the miR-302s cluster (miR-302s-piPSC) and investigated the early reprogramming events during the miRNA induction process. The results showed that miR-302s-piPSCs exhibited some characteristics of pluripotent stem cells including expression of pluripotency markers-particularly, efficient activation of endogenous OCT4-and differentiation to the three germ layers in vitro. During the early reprogramming process, somatic cells first underwent epithelial-mesenchymal transition and then mesenchymal-epithelial transition to eventually form miR-302s-piPSCs. These data show, for the first time, that single factor miR-302s successfully induced pig somatic cells into miR-302s-piPSCs. This study provides a new tool and research direction for the induction of pluripotent stem cells in a large livestock.


Subject(s)
Cell Differentiation , Cellular Reprogramming , Epithelial-Mesenchymal Transition , Fetus/cytology , Fibroblasts/cytology , Induced Pluripotent Stem Cells/cytology , MicroRNAs/genetics , Animals , Cells, Cultured , Fetus/metabolism , Fibroblasts/metabolism , Induced Pluripotent Stem Cells/metabolism , Octamer Transcription Factor-3/metabolism , Swine , Swine, Miniature , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL